Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TFX Teleflex Incorporated | ABBV AbbVie |
|---|---|---|
| Price | $126.11 -0.2% | $259.93 -1.3% |
| StockIQ Score | 43D Weak Risk: Medium | 48D+ Moderate Risk: High |
| Technical | 30F | 41D |
| Fundamental | 40D | 57C |
| Growth | 37F | 34F |
| Fair Value | 38F | 33F |
| News | 100A+ | 98A+ |
| Quality | 42D | 42D |
| Risk | 48D+ | 44D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Teleflex (TFX) has a weaker overall rating ("WEAK" vs. "MODERATE") and lower scores across most categories. AbbVie (ABBV) leads in investor confidence (48 vs. 43) and excels in fundamentals (57 vs. 40), making it stronger in stability and financial health. TFX’s technical score (30) is also notably lower than ABBV’s (41).
